On 7 October, Citi lowered its rating on OCBC and expects flat third-quarter earnings, while UOB Kay Hian kept OCBC as its preferred pick, citing first-half earnings growth of 22%. Two brokers can read the same bank differently because they assume different things. Here is what each one assumes, and three questions you can ask of any rating.
Citi cut OCBC to a negative rating and expected flat third-quarter earnings, sending the shares down as much as 5.2%. Yet UOB Kay Hian kept OCBC as its preferred pick, pointing to wealth management and 22% first-half earnings growth. I explain how two brokers can read the same bank differently, and give you three questions to ask before reacting to the next red number on your screen. Iggy’s Forensic Zone: Zone verdict not issued.
Key takeaways:
Citi set a target price of $27.50, about 10% below the reported price.
OCBC trading exceeded 12 million shares and $374 million in value.
UOB Kay Hian cited 22% year-on-year first-half earnings growth.
Separate past performance from forward expectations before judging a rating.
Test each call against OCBC’s results and your own portfolio needs.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor. I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered.
Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle. Stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst. These carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors.
All data is sourced from public filings and verified sources. Where data is unverified, it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
